Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Medchemcomm. 2014 Dec 16;6(4):613–618. doi: 10.1039/C4MD00401A

Figure 4.

Figure 4

In silico analysis of the binding of 1 0 to HDAC2. Panel A: Compound 1 0 bound in the HDAC2 catalytic site. Panel B: Summary of critical contacts between 10 and HDAC2. Panel C: Summary of critical contacts between 4-(acetylamino)-N-[2-amino-5-(thiophen-2- yl)phenyl]benzamide and HDAC2.